Champions Oncology, Inc. (FRA:2I3)
Germany flag Germany · Delayed Price · Currency is EUR
5.85
+0.65 (12.50%)
At close: Dec 19, 2025

Champions Oncology Ratios and Metrics

Millions EUR. Fiscal year is May - Apr.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Dec '25 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 2016 - 2020
8686626099119
Upgrade
Market Cap Growth
54.14%40.09%2.01%-38.66%-17.49%42.38%
Upgrade
Enterprise Value
8389655899119
Upgrade
Last Close Price
5.856.404.504.427.409.15
Upgrade
PE Ratio
39.6220.85--189.51396.90
Upgrade
PS Ratio
1.691.721.321.242.123.50
Upgrade
PB Ratio
23.3225.98-34.6514.3911.4219.34
Upgrade
P/TBV Ratio
25.7328.51-15.5111.8520.26
Upgrade
P/FCF Ratio
17.5014.01-60.6425.25-
Upgrade
P/OCF Ratio
15.8613.27-16.8015.99-
Upgrade
EV/Sales Ratio
1.661.781.381.192.133.48
Upgrade
EV/EBITDA Ratio
16.7815.65--46.9092.05
Upgrade
EV/EBIT Ratio
39.4720.94--172.63389.82
Upgrade
EV/FCF Ratio
16.9714.51-58.1225.48-
Upgrade
Debt / Equity Ratio
1.281.68-3.901.861.041.29
Upgrade
Debt / EBITDA Ratio
0.930.76--2.293.37
Upgrade
Debt / FCF Ratio
0.960.90-7.822.30-
Upgrade
Asset Turnover
2.111.951.661.551.561.70
Upgrade
Quick Ratio
0.910.880.560.831.061.04
Upgrade
Current Ratio
0.960.940.630.901.131.13
Upgrade
Return on Equity (ROE)
98.94%503.05%-532.46%-77.70%6.63%5.78%
Upgrade
Return on Assets (ROA)
5.56%10.36%-14.31%-7.98%1.21%0.95%
Upgrade
Return on Capital (ROIC)
18.00%38.77%-46.11%-17.49%2.13%1.76%
Upgrade
Return on Capital Employed (ROCE)
30.70%57.10%-150.80%-35.40%3.40%2.20%
Upgrade
Earnings Yield
2.52%4.80%-11.04%-8.00%0.53%0.25%
Upgrade
FCF Yield
5.72%7.14%-10.58%1.65%3.96%-3.45%
Upgrade
Buyback Yield / Dilution
-4.06%-5.31%-0.04%4.37%2.84%-23.05%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.